Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05360901 · ClinicalTrials.gov registry record · NA

Toward Understanding Drivers of Patient Engagement With Digital Mental Health Interventions - Part I

A NA study, sponsored by Brigham and Women's Hospital.

Completed
Registry status
NA
Development phase
12
Enrollment target

NCT05360901: Completed NA study, sponsored by Brigham and Women's Hospital.

NCT05360901 is a NA study that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 12 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05360901, a NA study, has completed, sponsored by Brigham and Women's Hospital.

COMPLETED
Registry status
NA
Development phase
12 participants
Enrollment target

Study Summary

This pilot study is a precursor to a subsequent clinical trial that will test the impact of a set of automated motivational messages on patient engagement with a digital mental health intervention. The pilot study aims to systematically employ patient feedback to develop the automated motivational messages that will be used in the subsequent clinical trial.

Primary Outcome

Mean Likert scale rating of how well participants felt each message motivated them to use the digital mental health intervention as rated within 24 hours of message delivery. The Likert scale will range from 1 (not at all motivating) to 10 (very motivating) with a score of 5 being neutral.

Interventions

  • BEHAVIORAL IntelliCare with automated motivational messaging

Trial Details

FieldValue
Enrollment Target 12 participants
Start Date 2022-07-06
Est. Completion 2022-10-17
Phase NA
Brigham and Women's Hospital

937 total trials

What the finished NCT05360901 record still lists

NCT05360901 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 1 intervention - of which IntelliCare with automated motivational messaging is the first listed.

NCT05360901 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05360901 about?

NCT05360901 is a clinical study titled "Toward Understanding Drivers of Patient Engagement With Digital Mental Health Interventions - Part I". This pilot study is a precursor to a subsequent clinical trial that will test the impact of a set of automated motivational messages on patient engagement with a digital mental health intervention. The pilot study aims to systematically employ patient feedback to develop the automated motivational m...

What is the current status of trial NCT05360901?

This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2022-07-06. Estimated completion is 2022-10-17.

What interventions are being tested in trial NCT05360901?

The interventions under investigation include: IntelliCare with automated motivational messaging (BEHAVIORAL).

Who is sponsoring clinical trial NCT05360901?

This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05360901's enrollment target sits among peer trials

12 1913th of 2000 higher than 74 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02602769 · 12 participants

    Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome

  • NCT02605421 · 12 participants · Phase 2

    Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma

  • NCT02619448 · 12 participants · Early Phase 1

    Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC

  • NCT03311503 · 12 participants · Phase 1

    Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05360901, the US trial registry maintained by the National Library of Medicine. NCT05360901 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.